USPTO Rejects : vimarsana.com

On January 18, 2024, the USPTO rejected a "contingent" terminal disclaimer filed by Acadia Pharmaceuticals Inc. (Acadia) for a patent it owns...

Related Keywords

Delaware , United States , , Acadia Pharmaceuticals Inc , Pharmaceuticals Inc , Aurobindo Pharma Ltd , Acadia Pharmaceuticals , Abbreviated New Drug Application , Orange Book Listed , Patent Term Adjustment , Patent Term , Contingent Terminal Disclaimer , Terminal Disclaimer , Contingent Terminal , Federal Circuit , Mondaq , Uspto Rejects Quot Contingent Terminal Disclaimer , Intellectual Property , Patent , Litigation , Ediation Amp Arbitration , Trials Amp Appeals Compensation ,